Table 1 Demographic characteristics related to hepatitis B virus infection among blood donor candidates in Luanda, Angola.

From: Trends in active hepatitis B virus infection and associated risk factors among blood donor candidates from Luanda, Angola

Independent variables

N (%)

Active Hepatitis B Virus infection (HBsAg)

Prevalence ratio (PR)

Non-reactive (%; 95% CI)

Reactive (%; 95% CI)

P-value

PR (95% CI)

P-value

Overall

96,654 (100)

86,986 (90.0; 89.8–90.2)

9668 (10.0; 9.4–10.6)

   

Age (years), Mean ± SD

34.0 ± 8.69

34.2 ± 8.74

32.7 ± 8.08

< 0.001

  

Age distribution

 18–29 yrs

34,253 (35.4)

30,346 (88.6; 88.2–89.0)

3907 (11.4; 10.4–12.4)

< 0.001

1.52 (1.43–1.60)

< 0.001

 30–40 yrs

41,604 (43.0)

37,408 (89.9; 89.6–90.2)

4196 (10.1; 9.19–11.0)

 

1.34 (1.27–1.42)

< 0.001

 >40 yrs

20,797 (21.5)

19,232 (92.5; 92.1–92.9)

1565 (7.50; 6.2–8.8)

 

1.00

 

Gender

 Female

9920 (10.3)

9166 (92.4; 91.9–92.9)

754 (7.60; 5.71–9.49)

< 0.001

1.00

 

 Male

86,734 (89.7)

77,820 (89.7; 89.5–89.9)

8914 (10.3; 9.67–10.9)

 

1.35 (1.26–1.45)

< 0.001

Occupation

 Unemployed

6736 (7.0)

6494 (96.4; 96.0–96.9)

242 (3.6; 1.25–5.95)

< 0.001

1.00

 

 Employed

73,961 (76.5)

66,523 (89.9; 89.7–90.1)

7438 (10.1; 9.42–10.8)

 

2.80 (2.47–3.17)

< 0.001

 Student

15,957 (16.5)

13,969 (87.5; 87.0–88.1)

1988 (12.5; 11.1–14.0)

 

3.47 (3.04–3.95)

< 0.001

Residence

 Non-urbanized

93,390 (96.6)

83,999 (89.9; 89.7–90.1)

9391 (10.1; 9.49–10.7)

0.003

1.19 (1.06–1.33)

0.004

 Urbanized

3264 (3.4)

2987 (91.5; 90.5–92.5)

277 (8.5; 5.22–11.8)

 

1.00

 

Marital status

 Unmarried

89,695 (92.8)

80,488 (89.7; 89.5–89.9)

9207 (10.3; 9.68–10.9)

< 0.001

1.00

 

 Married

6959 (7.2)

6498 (93.4; 92.8–94.0)

461 (6.6; 4.33–8.87)

 

0.65 (0.59–0.71)

< 0.001

Year of diagnosis

 2018

16,391 (17.0)

14,629 (89.3; 88.8–89.8)

1762 (10.7; 9.26–12.1)

< 0.001

1.17 (1.10–1.24)

< 0.001

 2019

16,356 (16.9)

14,732 (90.1; 89.6–90.6)

1624 (9.9; 8.45–11.4)

 

1.08 (1.02–1.15)

0.014

2020

18,722 (19.4)

16,884 (90.2; 89.8–90.7)

1838 (9.8; 8.44–11.2)

 

1.07 (1.01–1.13)

0.029

 2021

22,192 (23.0)

19,861 (89.5; 89.1–89.9)

2331 (10.5; 9.26–11.7)

 

1.14 (1.08–1.21)

< 0.001

 2022

22,993 (23.8)

20,880 (90.8; 90.4–91.2)

2113 (9.2; 7.97–10.4)

 

1.00

 
  1. Bold number means that the results were statistically significant for the Che-square test, Independent-samples t-test or Prevalence Ratio calculated through the generalized linear model (GLM) with a Poisson distribution (p < 0.05).